Thursday, March 12, 2026
ADVT 
International

1 in 6 people in England, Wales born abroad, mostly India: Census

Darpan News Desk IANS, 08 Nov, 2022 11:59 AM
  • 1 in 6 people in England, Wales born abroad, mostly India: Census

London, Nov 8 (IANS) India was found to be the most common country of birth for one in six, or nearly 10 million, people in England and Wales, according to a report released by the UK's Office for National Statistics.

The report, "International Migration, England and Wales: Census 2021", said that 16.8 per cent of residents were born abroad, up from 13.4 per cent a decade earlier.

The number of foreign-born residents increased by 2.5 million over the decade to 10 million.

India was the most common country of origin, accounting for 920,000 people, which is 1.5 per cent of the usual resident population, the 2021 census showed.

The three most common non-UK countries of birth for usual residents in 2021 were India, followed by Poland, which increased to 743,000 (1.2 per cent), up from 579,000 in 2011; and Pakistan, which increased to 624,000 (1 per cent), up from 482,000 in 2011.

The report comes at a time when the UK has been under duress over record number of migrants crossing the English Channel in small boats and arriving in Britain.

Migration led to a 6.3 per cent rise in the population between 2011 and 2021, the report said.

The figures also showed that 5.9 million people, or 9.9 per cent of the population, held a non-UK passport.

London continued to be the region with the largest proportion of people born outside the UK, rising from 36.7 per cent in 2011 to 40.6 per cent of the city's population.

The figures for Wales and North East England were less than 7 per cent.

MORE International ARTICLES

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK